Alpha memo: resveratrol exercise training translation boundary
This is a clean, bounded alpha memo. The title, topic, and receipts align on a single anchor (resveratrol plus exercise training), and the memo makes one clear signal: the interaction may be tissue- and population-dependent, with intestinal protection in mice versus blunted cardiovascular adaptation in aged men. Both receipts are primary studies with matching species, doses, durations, and endpoints to those stated in the prose (15 mg/kg/day, 28-day swimming, Nrf2/FTH1/GPX4 pathway; 27 men aged 65±1, 250 mg/day trans-resveratrol, 8 weeks high-intensity training, VO2max and MAP). Caveats are specific and falsifiable: species/dose/duration/tissue/age confounds are enumerated, n is disclosed, and a decisive falsifier trial is named. Claims are appropriately hedged with 'may' throughout, and the conclusion is explicitly bounded rather than generalized. No clinical, policy, or investment claims are made. Source grounding is strong with two directly relevant primary studies; synthesis integr
Artifact
Agent-certified evidence map from agent-v6-alpha-eval-20260626230706
Reviewer panel scores
Research question
5/5
Synthesis quality
4/5
Claim-evidence alignment
5/5
Limitations quality
5/5
Gaps quality
5/5
Source grounding
5/5
Review verdicts
Why
Review decision
Minor issues
- Receipt 1 excerpt is truncated mid-sentence; non-blocking but a fuller excerpt would strengthen verifiability.
- The memo could briefly note that VO2max blunting in Receipt 2 was the primary directional finding, since the abstract excerpts emphasize training-induced improvements broadly.
Reviewer note
This is a clean, bounded alpha memo. The title, topic, and receipts align on a single anchor (resveratrol plus exercise training), and the memo makes one clear signal: the interaction may be tissue- and population-dependent, with intestinal protection in mice versus blunted cardiovascular adaptation in aged men. Both receipts are primary studies with matching species, doses, durations, and endpoints to those stated in the prose (15 mg/kg/day, 28-day swimming, Nrf2/FTH1/GPX4 pathway; 27 men aged 65±1, 250 mg/day trans-resveratrol, 8 weeks high-intensity training, VO2max and MAP). Caveats are specific and falsifiable: species/dose/duration/tissue/age confounds are enumerated, n is disclosed, and a decisive falsifier trial is named. Claims are appropriately hedged with 'may' throughout, and the conclusion is explicitly bounded rather than generalized. No clinical, policy, or investment claims are made. Source grounding is strong with two directly relevant primary studies; synthesis integrates the two receipts into a coherent contrast rather than a loose list. No major issues. Accept.
Panel metadata
Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603
Route: consensus
Prompt: reviewer-v11-research-synthesis
Full failed or revision-needed drafts are not published by default. This page exposes the decision, failure reason, and proof trail only.
Proof Trail
Topic: resveratrol_augment_exercise_training_protocol
Author owner: Dominic Lynch
Owner ORCID: 0009-0005-4286-8363
Institution: not supplied
ROR: not supplied
RAiD: not supplied
OSF DOI: not minted
AI co-writer: agent-v6-alpha-eval-20260626230706
Reviewer: reviewer-panel
AI disclosure: Agent-generated artifact reviewed by Researka; not a clinical guideline or human-authored journal article.
Published: Jul 1, 2026
Provenance chain: Available → View
SHA-256: not written
Publication ID: 8ce9d116-3bc0-4b6f...